BCYC
Price
$8.16
Change
-$0.49 (-5.66%)
Updated
Oct 17, 04:59 PM (EDT)
Capitalization
599.5M
13 days until earnings call
Intraday Buy/Sell Signals
MLTX
Price
$9.09
Change
-$0.29 (-3.09%)
Updated
Oct 17, 04:59 PM (EDT)
Capitalization
595.64M
32 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

BCYC vs MLTX

Header iconBCYC vs MLTX Comparison
Open Charts BCYC vs MLTXBanner chart's image
Bicycle Therapeutics
Price$8.16
Change-$0.49 (-5.66%)
Volume$2.69K
Capitalization599.5M
MoonLake Immunotherapeutics
Price$9.09
Change-$0.29 (-3.09%)
Volume$106.71K
Capitalization595.64M
BCYC vs MLTX Comparison Chart in %
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCYC vs. MLTX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and MLTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (BCYC: $8.65 vs. MLTX: $9.38)
Brand notoriety: BCYC and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 147% vs. MLTX: 85%
Market capitalization -- BCYC: $566.23M vs. MLTX: $579.13M
BCYC [@Biotechnology] is valued at $566.23M. MLTX’s [@Biotechnology] market capitalization is $579.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileMLTX’s FA Score has 1 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • MLTX’s FA Score: 1 green, 4 red.
According to our system of comparison, BCYC is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 5 TA indicator(s) are bullish while MLTX’s TA Score has 6 bullish TA indicator(s).

  • BCYC’s TA Score: 5 bullish, 4 bearish.
  • MLTX’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than MLTX.

Price Growth

BCYC (@Biotechnology) experienced а -2.48% price change this week, while MLTX (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +16.03%, and the average quarterly price growth was +79.42%.

Reported Earning Dates

BCYC is expected to report earnings on Oct 30, 2025.

MLTX is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCYC($600M) and MLTX($596M) have the same market capitalization . BCYC YTD gains are higher at: -38.214 vs. MLTX (-82.678). MLTX has higher annual earnings (EBITDA): -196.98M vs. BCYC (-240.81M). BCYC has more cash in the bank: 721M vs. MLTX (425M). BCYC has less debt than MLTX: BCYC (7.2M) vs MLTX (75.8M). BCYC has higher revenues than MLTX: BCYC (19.3M) vs MLTX (0).
BCYCMLTXBCYC / MLTX
Capitalization600M596M101%
EBITDA-240.81M-196.98M122%
Gain YTD-38.214-82.67846%
P/E RatioN/AN/A-
Revenue19.3M0-
Total Cash721M425M170%
Total Debt7.2M75.8M9%
FUNDAMENTALS RATINGS
BCYC: Fundamental Ratings
BCYC
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCMLTX
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
50%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
69%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
57%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 2 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 4 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYKAX97.93N/A
N/A
Rydex Banking H
FSCOX23.62N/A
N/A
Fidelity International Small Cap Opp
ATHWX21.22N/A
N/A
American Century Heritage R
FERIX66.40N/A
N/A
Fidelity Advisor Emerging Asia I
SCECX13.40N/A
N/A
Steward Values Enhanced SmMidCapI

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-5.16%
KALA - MLTX
89%
Closely correlated
-2.13%
IOBT - MLTX
78%
Closely correlated
+15.01%
NEVPF - MLTX
70%
Closely correlated
N/A
XNCR - MLTX
50%
Loosely correlated
+6.03%
NUVL - MLTX
48%
Loosely correlated
+0.87%
More